Why Hims & Hers Health, Inc.’s (HIMS) Stock Is Down 7.00%
As of Friday, August 28, Hims & Hers Health, Inc.’s HIMS share price has dipped by 7.00%, which has investors questioning if this is right time to buy.Jenna Brashear
Stock Evaluator: Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc. HIMS
$27.51
0.07
0.26%
September 11, 2026 4:00:03 PM
EST
Volume: 7,071,567
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.
Commentary & Analysis
Why Hims & Hers Health, Inc.’s (HIMS) Stock Is Down 5.45%
As of Wednesday, August 26, Hims & Hers Health, Inc.’s HIMS share price has dipped by 5.45%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Hims & Hers Health, Inc.’s (HIMS) Stock Is Down 8.97%
As of Monday, August 24, Hims & Hers Health, Inc.’s HIMS share price has dipped by 8.97%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Hims & Hers Health, Inc.’s (HIMS) Stock Is Up 6.28%
As of Friday, August 21, Hims & Hers Health, Inc.’s HIMS share price has surged by 6.28%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Hims & Hers Health, Inc.’s (HIMS) Stock Is Up 6.50%
As of Wednesday, August 19, Hims & Hers Health, Inc.’s HIMS share price has surged by 6.50%, which has investors questioning if this is right time to sell.Michael Rose
Financial Summary
| Share Statistics | HIMS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6,418.5 | $1,872.1 | 71% |
|
| Shares Out (Mil) | 231.7 | 76.7 | 79% |
|
| Institutional Ownership | 88.9% | 87.8% | 57% |
|
| Float (Mil) | 213.7 | 56.5 | 75% |
|
| Beta | 2.42 | 0.74 | 96% |
|
| Avg Daily Volume (000s) | 8,911 | 526 | 96% |
|
| Price Change (52-week) |
(42.4%) | 79.8% | 19% |
|
| Growth | HIMS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 73.6% | 10.4% | 98% |
|
| Net Income (5yr) | 55.5% | (0.2%) | 95% |
|
| EPS (5yr) | 24.6% | 3.0% | 75 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (28.5%) | (17.9%) | 21% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 7 | na | na | |
| Current EPS | $0.168 | na | na | |
| Month Ago EPS | $0.217 | na | na | |
| # Rev Up | 0 | na | na | |
| # Rev Down | 1 | na | na | |
| Three Months Ago EPS | $0.190 | na | na | |
| Year/Year Chg | (145.2%) | na | 179.1% | |
| Financials | HIMS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,578 | $1,504 | 64% |
|
| Net Income (TTM) (Mil) | ($142) | $28 | 9% |
|
| EPS (TTM) | ($0.622) | $0.200 | 26% |
|
| Operating Cash Flow (TTM) (Mil) | $264 | $162 | 62% |
|
| Net Cash Flow (TTM) (Mil) | ($515) | $8 | 6% |
|
| Long-Term Debt (Q1) (Mil) | $1,535 | $373 | 71% |
|
| Enterprise Value (Q1) (Mil) | $7,824 | $2,343 | 70% |
|
| Valuation | HIMS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 19.79 | 2.88 | 96% |
|
| P/E | na | 25.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | HIMS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 69.5% | 27.8% | 81% |
|
| Net Margin | (5.5%) | 1.3% | 24% |
|
| ROA | (5.2%) | 2.2% | 30% |
|
| ROE | (32.0%) | 7.2% | 19% |
|
| Liabilities to Assets | 91.1% | 60.5% | 88% |
|
| F-Score | 3 | 5 | 18% |
|
Hims & Hers Health, Inc. did not pass any screens on 9/11/2026.
